Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis

dc.contributor.authorRezvani, Aylin
dc.contributor.authorBodur, Hatice
dc.contributor.authorAtaman, Sebnem
dc.contributor.authorKaya, Taciser
dc.contributor.authorBugdayci, Derya Soy
dc.contributor.authorDemir, Saliha Eroglu
dc.contributor.authorKocyigit, Hikmet
dc.date.accessioned2020-03-26T18:49:55Z
dc.date.available2020-03-26T18:49:55Z
dc.date.issued2014
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjectives. To investigate the relationship between enthesitis and disease activity, functional status, fatigue, joint mobility, radiological damage, laboratory parameter and quality of life in patients with ankylosing spondylitis (AS). Methods. A total of 421 patients with AS (323 male and 98 female) who were included in the Turkish League Against Rheumatism Registry were enrolled in the study. The Bath AS Disease Activity Index (BASDAI), fatigue, the Bath AS Functional Index (BASFI), the Bath AS Metrology Index (BASMI), the Maastricht AS Enthesitis Score (MASES), AS quality of life (ASQoL), the Bath AS Radiology Index (BASRI) and erythrocyte sedimentation rate (ESR) were evaluated. Results. Enthesitis was detected in 27.3% of patients. There were positive correlations between MASES and BASDAI, BASFI and fatigue (p < 0.05). MASES was not correlated with BASRI, BASMI, ASQoL and ESR. The mean MASES score was 1.1 +/- 2.4. The most frequent regions of enthesopathies were right iliac crest, spinous process of L5 and proximal to the insertion of left achilles tendon, respectively. Conclusions. Enthesitis was found to be associated with higher disease activity, higher fatigue, worse functional status and lower disease duration. As enthesitis was correlated with BASDAI, we conclude that enthesitis can reflect the disease activity in patients with AS.en_US
dc.description.sponsorshipPfizer Companyen_US
dc.description.sponsorshipThe authors express their gratitude to all members of the TRASD-IP AS Study group for their cooperation and to Pfizer Company for the registry sponsorship.en_US
dc.identifier.doi10.3109/14397595.2013.850182en_US
dc.identifier.endpage656en_US
dc.identifier.issn1439-7595en_US
dc.identifier.issn1439-7609en_US
dc.identifier.issue4en_US
dc.identifier.pmid24252034en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage651en_US
dc.identifier.urihttps://dx.doi.org/10.3109/14397595.2013.850182
dc.identifier.urihttps://hdl.handle.net/20.500.12395/30710
dc.identifier.volume24en_US
dc.identifier.wosWOS:000338636500018en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTAYLOR & FRANCIS LTDen_US
dc.relation.ispartofMODERN RHEUMATOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectAnkylosing spondylitisen_US
dc.subjectDisease activity parametersen_US
dc.subjectEnthesitis scoresen_US
dc.subjectMASESen_US
dc.subjectQuality of lifeen_US
dc.titleCorrelations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitisen_US
dc.typeArticleen_US

Dosyalar